Cholinergic modification of naloxone-induced jumping in morphine dependent mice.
D000818:Animals; D001115:Arecoline / Q000494:pharmacology; D001285:Atropine / Q000494:pharmacology; D001522:Behavior, Animal / Q000187:drug effects*; D001590:Benztropine / Q000494:pharmacology; D001923:Brain Chemistry / Q000187:drug effects; D004246:Dimethylphenylpiperazinium Iodide / Q000494:pharmacology; D006801:Humans; D008120:Lobeline / Q000494:pharmacology; D008297:Male; D008464:Mecamylamine / Q000494:pharmacology; D051379:Mice; D008813:Mice, Inbred ICR; D009021:Morphine Dependence; D009270:Naloxone / Q000494:pharmacology*; D009538:Nicotine / Q000494:pharmacology; D010095:Oxotremorine / Q000494:pharmacology; D010276:Parasympatholytics / Q000494:pharmacology*; D010277:Parasympathomimetics / Q000494:pharmacology*; D010393:Pempidine / Q000494:pharmacology; D010830:Physostigmine / Q000494:pharmacology; D010862:Pilocarpine / Q000494:pharmacology; D014203:Tremorine / Q000494:pharmacology; D014316:Tritium
D010276:Parasympatholytics; D010277:Parasympathomimetics; D010862:Pilocarpine; D014316:Tritium; D001590:Benztropine; D009270:Naloxone; D001115:Arecoline; D004246:Dimethylphenylpiperazinium Iodide; D010095:Oxotremorine; D008464:Mecamylamine; D009538:Nicotine; D001285:Atropine; D010830:Physostigmine; D008120:Lobeline; D010393:Pempidine; D014203:Tremorine